Michael Lill

3.7k total citations
62 papers, 1.8k citations indexed

About

Michael Lill is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Michael Lill has authored 62 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 17 papers in Oncology and 13 papers in Genetics. Recurrent topics in Michael Lill's work include Hematopoietic Stem Cell Transplantation (18 papers), Lymphoma Diagnosis and Treatment (11 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Michael Lill is often cited by papers focused on Hematopoietic Stem Cell Transplantation (18 papers), Lymphoma Diagnosis and Treatment (11 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Michael Lill collaborates with scholars based in United States, United Kingdom and Canada. Michael Lill's co-authors include Raj Makkar, John Child, Joseph K. Perloff, Peng‐Sheng Chen, Sergio Giralt, John A. Glaspy, Gary J. Schiller, Matthew J. Price, James S. Forrester and Malka Frantzen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of the American College of Cardiology.

In The Last Decade

Michael Lill

61 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Lill United States	22	919	460	365	325	319	62	1.8k
Herbert G. Sayer Germany	24	1.4k 1.5×	533 1.2×	306 0.8×	492 1.5×	475 1.5×	90	2.1k
Donna Skerrett United States	18	398 0.4×	448 1.0×	348 1.0×	183 0.6×	229 0.7×	41	1.1k
Julie‐An Talano United States	19	740 0.8×	593 1.3×	183 0.5×	236 0.7×	179 0.6×	70	1.4k
Jason Tay Canada	20	693 0.8×	321 0.7×	219 0.6×	341 1.0×	394 1.2×	108	1.6k
Sucha Nand United States	22	814 0.9×	339 0.7×	305 0.8×	199 0.6×	452 1.4×	72	1.6k
Osman İlhan Türkiye	21	870 0.9×	431 0.9×	165 0.5×	374 1.2×	153 0.5×	167	1.7k
Frederick Hagemeister United States	27	389 0.4×	1.0k 2.2×	201 0.6×	1.7k 5.3×	488 1.5×	69	3.3k
H. Kent Holland United States	22	2.1k 2.3×	795 1.7×	278 0.8×	921 2.8×	268 0.8×	100	3.1k
Maria Gilleece United Kingdom	20	535 0.6×	405 0.9×	134 0.4×	278 0.9×	299 0.9×	54	1.4k
Paola Fazi Italy	24	1.7k 1.8×	378 0.8×	119 0.3×	392 1.2×	603 1.9×	78	2.3k

Countries citing papers authored by Michael Lill

Since Specialization

Citations

This map shows the geographic impact of Michael Lill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lill more than expected).

Fields of papers citing papers by Michael Lill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lill. The network helps show where Michael Lill may publish in the future.

Co-authorship network of co-authors of Michael Lill

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lill. A scholar is included among the top collaborators of Michael Lill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lill. Michael Lill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bharadwaj, Parag, et al.. (2020). Aligning Palliative Care with Cure: Experience of Integrating with Hematopoietic Stem Cell Transplant. Journal of Palliative Medicine. 23(2). 162–163. 1 indexed citations

LeMaistre, Charles F., Luke P. Akard, Dennis A. Gastineau, et al.. (2019). Integration of Publicly Reported Center Outcomes into Standards and Accreditation: The FACT Model. Biology of Blood and Marrow Transplantation. 25(11). 2243–2250. 4 indexed citations

Takao, Sumiko, Wenwen Chien, Vikas Madan, et al.. (2017). Targeting the vulnerability to NAD+ depletion in B-cell acute lymphoblastic leukemia. Leukemia. 32(3). 616–625. 30 indexed citations

Gajewski, James, Mark McClellan, Navneet S. Majhail, et al.. (2017). Payment and Care for Hematopoietic Cell Transplantation Patients: Toward a Specialized Medical Home for Complex Care Patients. Biology of Blood and Marrow Transplantation. 24(1). 4–12. 4 indexed citations

Cheng, Yee Chung, Yu‐Shu Shi, Mei-Jie Zhang, et al.. (2017). Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation. Journal of Cancer. 8(6). 1009–1017. 6 indexed citations

Ding, Ling‐Wen, Takayuki Ikezoe, M Mori, et al.. (2016). Mutational profiling of a MonoMAC syndrome family with GATA2 deficiency. Leukemia. 31(1). 244–245. 24 indexed citations

Jilaihawi, Hasan, Niraj Doctor, Tarun Chakravarty, et al.. (2014). Major thrombocytopenia after balloon‐expandable transcatheter aortic valve replacement: Prognostic implications and comparison to surgical aortic valve replacement. Catheterization and Cardiovascular Interventions. 85(1). 130–137. 41 indexed citations

Törlén, Johan, Olle Ringdén, Jennifer Le Rademacher, et al.. (2014). Low CD34 Dose Is Associated with Poor Survival after Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome. Biology of Blood and Marrow Transplantation. 20(9). 1418–1425. 34 indexed citations

Bensinger, William, Pamela S. Becker, Ted Gooley, et al.. (2012). Randomized Comparison of Melphalan 200 Mg/m2 v. 280 Mg/m2 As a Preparative Regimen for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation. Blood. 120(21). 2009–2009. 2 indexed citations

10.

Luger, Selina M., Olle Ringdén, M-J Zhang, et al.. (2011). Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. Bone Marrow Transplantation. 47(2). 203–211. 194 indexed citations

11.

Bollu, Vamsi, Alfonso Quintás‐Cardama, Maria Flamm, et al.. (2011). PCN12 RESOURCE UTILIZATION AND PERCEPTIONS OF MAJOR MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA (CML): RESULTS OF A DELPHI PANEL STUDY. Value in Health. 14(3). A156–A157. 5 indexed citations

12.

Hatada, Seigo, William G. Walton, Raymond G. Fox, et al.. (2010). Therapeutic benefits in thalassemic mice transplanted with long-term−cultured bone marrow cells. Experimental Hematology. 39(3). 375–383.e4. 1 indexed citations

13.

Gajewski, James, C. Frederick LeMaistre, Samuel Silver, et al.. (2009). Impending Challenges in the Hematopoietic Stem Cell Transplantation Physician Workforce. Biology of Blood and Marrow Transplantation. 15(12). 1493–1501. 45 indexed citations

14.

Lazarus, Hillard M., Patrick J. Stiff, Jeanette Carreras, et al.. (2007). Utility of Single versus Tandem Autotransplants for Advanced Testes/Germ Cell Cancer: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis. Biology of Blood and Marrow Transplantation. 13(7). 778–789. 7 indexed citations

15.

Price, Matthew J., Chung‐Chuan Chou, Malka Frantzen, et al.. (2004). 1100-55 Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters ventricular electrophysiologic properties. Journal of the American College of Cardiology. 43(5). A63–A63. 2 indexed citations

16.

Qayyum, Mohammed, Kaname Takizawa, Malka Frantzen, et al.. (2002). Mesenchymal stem cell therapy prevents deterioration of left ventricular function in a porcine myocardial infarction model. Journal of the American College of Cardiology. 39. 169–169. 4 indexed citations

17.

Pak, Hui‐Nam, Mohammed Qayyum, Angela Lai, et al.. (2002). Mesenchymal Stern Cell injection induces cardiac nerve sprouting and tenascin expression in a swine model of myocardial infarction. Journal of the American College of Cardiology. 39. 445–445. 1 indexed citations

18.

Fraser, John K., Mitchell S. Cairo, Elizabeth L. Wagner, et al.. (1998). Cord Blood Transplantation Study (COBLT): Cord Blood Bank Standard Operating Procedures. Journal of Hematotherapy. 7(6). 521–561. 84 indexed citations

19.

Schiller, Gary J., Timothy A. Miller, Michael Lill, et al.. (1997). Transplantation of autologous peripheral blood progenitor cells procured after high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia in first remission. Leukemia. 11(9). 1533–1539. 18 indexed citations

20.

Morstyn, George, John A. Glaspy, Elizabeth J. Shpall, et al.. (1994). Clinical Applications of Filgrastim and Stem Cell Factor In Vivo and In Vitro. Journal of Hematotherapy. 3(4). 353–355. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact